Valuation: Becton, Dickinson and Company

Market Cap 45.64B 39.53B 36.82B 33.82B 63.95B 4,352B 64.79B 434B 170B 2,169B 171B 168B 7,178B P/E 2026 *
36.1x
P/E 2027 * 23.5x
Enterprise Value 61.83B 53.55B 49.88B 45.83B 86.64B 5,897B 87.78B 587B 230B 2,938B 232B 227B 9,725B EV / Sales 2026 *
3.22x
EV / Sales 2027 * 3.01x
Free-Float
74.04%
Yield 2026 *
2.37%
Yield 2027 * 2.4%
1 day-2.60%
1 week+7.51%
1 month+9.55%
3 months+14.66%
6 months-14.87%
Current year-13.05%
1 week 137
Extreme 137
147.8
1 month 131.3
Extreme 131.3
147.8
Current year 121
Extreme 121
179
1 year 121
Extreme 121
179
3 years 121
Extreme 121
261
5 years 121
Extreme 121
265
10 years 121
Extreme 121
265
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.60%+7.51% - - 45.64B
+0.09%+2.56%-16.96%-4.37% 183B
-0.37%+2.62%-4.42%-2.61% 109B
-0.29%+0.47%+7.97%+64.64% 60.57B
+3.50%+0.47%+41.00%+46.44% 51.8B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+5.26%-31.60% 31.49B
+0.40%+3.89%+42.51%-8.26% 24B
-1.22%+6.69%+0.67%+1.96% 22.26B
-3.79%+7.37%-9.34%-0.68% 21.51B
Average +0.81%+5.02%+8.34%+8.19% 59.67B
Weighted average by Cap. +0.54%+3.44%+0.04%+8.08%

Financials

2026 *2027 *
Net sales 19.21B 16.64B 15.5B 14.24B 26.92B 1,832B 27.28B 183B 71.61B 913B 72.15B 70.57B 3,022B 19.72B 17.08B 15.91B 14.62B 27.64B 1,881B 28B 187B 73.51B 937B 74.07B 72.44B 3,102B
Net income 1.29B 1.12B 1.04B 956M 1.81B 123B 1.83B 12.25B 4.81B 61.29B 4.84B 4.74B 203B 1.98B 1.71B 1.59B 1.46B 2.77B 188B 2.8B 18.77B 7.36B 93.87B 7.42B 7.25B 311B
Net Debt 16.19B 14.03B 13.07B 12B 22.69B 1,544B 22.99B 154B 60.36B 770B 60.81B 59.47B 2,547B 13.82B 11.97B 11.15B 10.24B 19.36B 1,318B 19.62B 131B 51.5B 657B 51.88B 50.74B 2,173B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
31/07/26 €143.95 -2.60% 0
30/07/26 €147.80 +1.93% 20
29/07/26 €145.00 +3.68% 160
28/07/26 €139.85 +2.08% 0
27/07/26 €137.00 +2.32% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
165.62USD
Average target price
180.25USD
Spread / Average Target
+8.83%

Quarterly revenue - Rate of surprise